Posted on April 30, 2014 by Sitemaster
In one of the more important lectures at the upcoming annual meeting of the American Urological Association, starting in Orlando in a couple of weeks’ time, Dr. Peter Albertsen will be reviewing contemporary recommendations on the practice of active surveillance (AS) for men with low- and very low-risk prostate cancer. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: active suirveillance, candidate, monitoring, reccommendation | Leave a comment »
Posted on March 19, 2009 by Sitemaster
There are six new reports in today’s news, of which the most immediately important would seem to be:
- How men manage their “fear” while on active surveillance
- “Cancer anxiety” and early use of hormonal therapy
- Approval for a Phase III clinical trial of MDV3100 … READ MORE …
Filed under: Diagnosis, Drugs in development, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: active suirveillance, cancer anxiety, denosumab, forkhead transcription factors, FOX factors, hormone therapy, MDV3100, testosterone | Leave a comment »